CIBC Private Wealth Group’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $24.7K | Hold |
385
| – | – | ﹤0.01% | 1935 |
|
2025
Q1 | $21.6K | Sell |
385
-1,000
| -72% | -$56K | ﹤0.01% | 1963 |
|
2024
Q4 | $95.5K | Hold |
1,385
| – | – | ﹤0.01% | 1435 |
|
2024
Q3 | $96.7K | Hold |
1,385
| – | – | ﹤0.01% | 1496 |
|
2024
Q2 | $90.6K | Hold |
1,385
| – | – | ﹤0.01% | 1441 |
|
2024
Q1 | $89.2K | Buy |
+1,385
| New | +$89.2K | ﹤0.01% | 1444 |
|
2018
Q3 | – | Sell |
-2,925
| Closed | -$160K | – | 1484 |
|
2018
Q2 | $160K | Hold |
2,925
| – | – | ﹤0.01% | 955 |
|
2018
Q1 | $144K | Hold |
2,925
| – | – | ﹤0.01% | 962 |
|
2017
Q4 | $138K | Buy |
+2,925
| New | +$138K | ﹤0.01% | 985 |
|